Sidoti Csr Estimates Balchem's Q1 Earnings (NASDAQ:BCPC)

Balchem Co. (NASDAQ:BCPC - Free Report) - Sidoti Csr increased their Q1 2025 earnings per share estimates for Balchem in a report released on Monday, October 28th. Sidoti Csr analyst K. May now forecasts that the basic materials company will post earnings of $1.19 per share for the quarter, up from their prior forecast of $1.16. The consensus estimate for Balchem's current full-year earnings is $3.96 per share. Sidoti Csr also issued estimates for Balchem's Q2 2025 earnings at $1.21 EPS, Q3 2025 earnings at $1.22 EPS, FY2025 earnings at $4.82 EPS and Q1 2026 earnings at $1.27 EPS.

Other research analysts also recently issued research reports about the stock. HC Wainwright boosted their price objective on shares of Balchem from $170.00 to $185.00 and gave the stock a "buy" rating in a report on Wednesday, July 31st. StockNews.com upgraded Balchem from a "hold" rating to a "buy" rating in a research note on Monday.

Balchem Stock Performance

BCPC stock traded down $0.38 on Wednesday, reaching $168.88. 92,225 shares of the company were exchanged, compared to its average volume of 107,052. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79. Balchem has a 12 month low of $114.97 and a 12 month high of $186.03. The stock's fifty day moving average price is $171.75 and its 200 day moving average price is $162.70. The firm has a market capitalization of $5.48 billion, a PE ratio of 47.82, a PEG ratio of 5.43 and a beta of 0.65.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. raised its stake in shares of Balchem by 1.5% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company's stock valued at $604,000 after buying an additional 59 shares in the last quarter. Inspire Investing LLC increased its stake in Balchem by 2.7% in the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company's stock valued at $413,000 after acquiring an additional 62 shares during the period. Hsbc Holdings PLC raised its position in Balchem by 1.5% in the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company's stock worth $757,000 after purchasing an additional 75 shares in the last quarter. Atomi Financial Group Inc. lifted its stake in Balchem by 6.1% during the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company's stock worth $295,000 after purchasing an additional 96 shares during the period. Finally, Xponance Inc. grew its stake in shares of Balchem by 5.2% in the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company's stock valued at $315,000 after purchasing an additional 102 shares during the period. 87.91% of the stock is owned by institutional investors.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.